| Blood glucose testing and primary prevention of Type 2 diabetes-evaluation of the effect of evidence-based patient information: a randomized controlled trial. | |
| | |
MedLine Citation:
|
PMID: 22133040 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Aims: To compare the effect of our newly developed online evidence-based patient information vs. standard patient information about sub-threshold elevated blood glucose levels and primary prevention of diabetes on informed patient decision making. Methods: We invited visitors to the cooperating health insurance company, Techniker Krankenkasse, and the German Diabetes Center websites to take part in a web-based randomized controlled trial. The population after randomization comprised 1120 individuals aged between 40 and 70 years without known diabetes, of whom 558 individuals were randomly assigned to the intervention group receiving evidence-based patient information, and 562 individuals were randomly assigned to the control group receiving standard information from the Internet. The primary endpoint was acquired knowledge of elevated blood glucose level issues and the secondary outcomes were attitude to metabolic testing, intention to undergo metabolic testing, decisional conflict and satisfaction with the information. Results: Overall, knowledge of elevated glucose level issues and the intention to undergo metabolic testing were high in both groups. Participants who had received evidence-based patient information, however, had significantly higher knowledge scores. The secondary outcomes in the evidence-based patient information subgroup that completed the 2-week follow-up period yielded significantly lower intention to undergo metabolic testing, significantly more critical attitude towards metabolic testing and significantly higher decisional conflict than the control subgroup (n = 466). Satisfaction with the information was not significantly different between both groups. Conclusions: Evidence-based patient information significantly increased knowledge about elevated glucose levels, but also increased decisional conflict and critical attitude to screening and treatment options. The intention to undergo metabolic screening decreased. Future studies are warranted to assess uptake of metabolic testing and satisfaction with this decision in a broader population of patients with unknown diabetes. © 2011 The Authors. Diabetic Medicine© 2011 Diabetes UK. |
| | |
Authors:
|
J Genz; B Haastert; H Müller; F Verheyen; D Cole; W Rathmann; B Nowotny; M Roden; G Giani; A Mielck; C Ohmann; A Icks |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-12-1 |
Journal Detail:
|
Title: Diabetic medicine : a journal of the British Diabetic Association Volume: - ISSN: 1464-5491 ISO Abbreviation: - Publication Date: 2011 Dec |
Date Detail:
|
Created Date: 2011-12-2 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8500858 Medline TA: Diabet Med Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Copyright Information:
|
© 2011 The Authors. Diabetic Medicine © 2011 Diabetes UK. |
Affiliation:
|
Institute of Biometrics and Epidemiology, German Diabetes Center, Leibniz Institute at the Heinrich Heine University Düsseldorf, Düsseldorf mediStatistica, Neuenrade WINEG-TK-Scientific Institute for Benefit and Efficiency in Health Care, Hamburg Institute of Clinical Diabetology, German Diabetes Center, Leibniz Institute at the Heinrich Heine University, Düsseldorf Helmholtz Zentrum München-German Research Center for Environmental Health, Institute of Health Economics and Health Care Management, Neuherberg Heinrich Heine University Düsseldorf, Coordination Center for Clinical Trials (KKS), Düsseldorf, Germany. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: It's not just the television: Survey analysis of sedentary behaviour in New Zealand young people.
Next Document: Efficacy of lycopene against fluoride toxicity in rats.